Arch Pharmalabs ties up with Orochem Technologies

Arch Pharmalabs recently signed a Technology Access & Services Agreement with Orochem Technologies Inc, on an exclusive basis. The agreement allows Arch to collaborate with Orochem for using Orochem’s proprietary Simulated Moving Bed (SMB) platform for pharmaceuticals and other applications, a statement from Orochem notified.

The statement also mentioned that SMB technology is an engineered process for implementing chromatographic separation. It is used to separate one chemical compound or one class of chemical compounds from one or more other chemical compounds to provide significant quantities of the purified or enriched material, more cost-effectively than obtained using simple (batch) chromatography. SMB Technology provides for the “highest purities” of industrial or “metric ton” scale purification for APIs, nutritional supplements, fatty acids and specialty sugars.

“….The partnership with Orochem provides Arch Pharmalabs vast opportunities for separation and purification of various small molecule Active Pharmaceutical Ingredients from its three US FDA-approved facilities in India. It also allows Arch Pharmalabs to collaborate with other pharmaceutical companies to conduct contract manufacturing of APIs at its Vitalife facility in Gurgaon. We look forward to this association with Orochem and expand the applications of their proprietary platform and offer unique solutions to the pharma industry worldwide,” the statement quoted Ajit Kamath, Chairman and Managing Director, Arch Pharmalabs, as saying.